• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
ALEXMED ePosters
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 7 (2025)
Volume Volume 6 (2024)
Volume Volume 5 (2023)
Volume Volume 4 (2022)
Volume Volume 3 (2021)
Volume Volume 2 (2020)
Issue Issue 2
Issue Issue 1
Volume Volume 1 (2019)
Badr Eldin Hussein, R. (2020). Measurements of HbA1c, and fasting plasma glucose in patients with polycystic ovary syndrome. ALEXMED ePosters, 2(2), 78-78. doi: 10.21608/alexpo.2020.54939.1091
Rania Badr Eldin Hussein. "Measurements of HbA1c, and fasting plasma glucose in patients with polycystic ovary syndrome". ALEXMED ePosters, 2, 2, 2020, 78-78. doi: 10.21608/alexpo.2020.54939.1091
Badr Eldin Hussein, R. (2020). 'Measurements of HbA1c, and fasting plasma glucose in patients with polycystic ovary syndrome', ALEXMED ePosters, 2(2), pp. 78-78. doi: 10.21608/alexpo.2020.54939.1091
Badr Eldin Hussein, R. Measurements of HbA1c, and fasting plasma glucose in patients with polycystic ovary syndrome. ALEXMED ePosters, 2020; 2(2): 78-78. doi: 10.21608/alexpo.2020.54939.1091

Measurements of HbA1c, and fasting plasma glucose in patients with polycystic ovary syndrome

Article 49, Volume 2, Issue 2, October 2020, Page 78-78  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2020.54939.1091
View on SCiNiTO View on SCiNiTO
Author
Rania Badr Eldin Hussein email
Internal medicine department, Faculty of medicine, Alexandria university, Egypt
Abstract
Polycystic ovary syndrome (PCOS) is a heterogeneous disease that is characterized by a combination of signs and symptoms of androgen excess (hirsutism and/or hyperandrogenemia) and ovarian dysfunction (oligo ovulation and/or polycystic ovarian morphology (PCOM)), provided that other specific diagnoses have been excluded.
The main features of PCOS include reduced fertility due to dysfunctional follicular maturation and ovulation, disturbance of reproductive hormones including luteinizing hormone (LH) hypersecretion, and hyperandrogenism which causes acne and hirsutism.
Insulin resistance and compensatory hyperinsulinism have been demonstrated to be related to androgen excess in PCOS, as according to many studies, insulin acts as a co gonadotropin on the ovaries, facilitate androgen secretion from the adrenal glands and modulate luteinizing hormone pulsatility.
Insulin resistance is considered a major risk factor for the development of type 2 diabetes mellitus in PCOS. Patients with PCOS are predisposed to consequences of IR such as: central obesity, acanthosis nigricans, hirsutism, and early pregnancy loss.
So, screening of all PCOS women for T2DM and prediabetes is mandatory.
Keywords
Diabetes; PCOS; Metabolic syndrome; FPG; HbA1c
Statistics
Article View: 257
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.